Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DOXORUBICIN/AE:

Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Renu K et al. Eur J Pharmacol. (2018)

Doxorubicin targets multiple players: A new view of an old problem. Cappetta D et al. Pharmacol Res. (2018)

Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity. Liu H et al. Mini Rev Med Chem. (2017)

Search results

Items: 1 to 20 of 10889

1.

Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.

Mokkarala M, Noda C, Malone C, Ramaswamy R, Akinwande O.

Anticancer Res. 2019 Jun;39(6):3071-3077. doi: 10.21873/anticanres.13442.

PMID:
31177151
2.

Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.

Yu D, Zhang S, Feng A, Xu D, Zhu Q, Mao Y, Zhao Y, Lv Y, Han C, Liu R, Tian Y.

Medicine (Baltimore). 2019 May;98(19):e15582. doi: 10.1097/MD.0000000000015582.

3.

Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report.

Zhao C, Xie X, Gai DZ, Wu D, Xin H, Yang T.

Medicine (Baltimore). 2019 May;98(19):e15535. doi: 10.1097/MD.0000000000015535.

4.

NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo.

Huang X, Liu Y, Yang X, Lai S, Zhang Y, Gu J, Li H, Xie Y, Xia Y.

Life Sci. 2019 Jun 15;227:94-100. doi: 10.1016/j.lfs.2019.04.044. Epub 2019 Apr 18.

PMID:
31004659
5.

Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway.

Yang X, Hu G, Lv L, Liu T, Qi L, Huang G, You D, Zhao J.

Pharm Biol. 2019 Dec;57(1):184-192. doi: 10.1080/13880209.2019.1582679.

6.

Polyelectrolyte Carboxymethyl Cellulose for Enhanced Delivery of Doxorubicin in MCF7 Breast Cancer Cells: Toxicological Evaluations in Mice Model.

Shafiei-Irannejad V, Rahimi M, Zarei M, Dinparast-Isaleh R, Bahrambeigi S, Alihemmati A, Shojaei S, Ghasemi Z, Yousefi B.

Pharm Res. 2019 Mar 18;36(5):68. doi: 10.1007/s11095-019-2598-3.

PMID:
30887127
7.

Effects of steroidal saponins extract from Ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response.

Wu Z, Zhao X, Miyamoto A, Zhao S, Liu C, Zheng W, Wang H.

Pharm Biol. 2019 Dec;57(1):176-183. doi: 10.1080/13880209.2019.1577467.

9.

β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats.

Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S.

Chem Biol Interact. 2019 May 1;304:158-167. doi: 10.1016/j.cbi.2019.02.028. Epub 2019 Mar 2.

PMID:
30836069
10.

Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?

Ruff C, Grözinger G, Syha R, Elser S, Partovi S, Bitzer M, Horger M, Nikolaou K, Grosse U.

J Vasc Interv Radiol. 2019 Mar;30(3):380-389.e4. doi: 10.1016/j.jvir.2018.09.001.

PMID:
30819480
11.

Oxidative stress injury in doxorubicin-induced cardiotoxicity.

Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S.

Toxicol Lett. 2019 Jun 1;307:41-48. doi: 10.1016/j.toxlet.2019.02.013. Epub 2019 Feb 25. Review.

PMID:
30817977
12.
13.

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.

Zaheed M, Wilcken N, Willson ML, O'Connell DL, Goodwin A.

Cochrane Database Syst Rev. 2019 Feb 18;2:CD012873. doi: 10.1002/14651858.CD012873.pub2.

PMID:
30776132
14.

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.

Kari E, Teppo HR, Haapasaari KM, Kuusisto MEL, Lemma A, Karihtala P, Pirinen R, Soini Y, Jantunen E, Turpeenniemi-Hujanen T, Kuittinen O.

J Clin Pathol. 2019 Apr;72(4):316-321. doi: 10.1136/jclinpath-2018-205584. Epub 2019 Feb 12.

15.

Genistein protects against doxorubicin-induced cardiotoxicity through Nrf-2/HO-1 signaling in mice model.

Bai Z, Wang Z.

Environ Toxicol. 2019 May;34(5):645-651. doi: 10.1002/tox.22730. Epub 2019 Feb 7.

PMID:
30734460
16.

Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards.

Lucatelli P, Argirò R, De Rubeis G, Rocco B, Corradini SG, Corona M, Nardis PG, Saba L, Mennini G, Fiorentino F, Corsi A, Catalano C, Bezzi M.

J Vasc Interv Radiol. 2019 Mar;30(3):305-313. doi: 10.1016/j.jvir.2018.10.026. Epub 2019 Jan 31.

PMID:
30713031
17.

Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.

Koleini N, Nickel BE, Edel AL, Fandrich RR, Ravandi A, Kardami E.

Chem Biol Interact. 2019 Apr 25;303:35-39. doi: 10.1016/j.cbi.2019.01.032. Epub 2019 Jan 29. Review.

PMID:
30707978
18.

A rare diagnosis of primary native kidney non-hodgkin's lymphoma after kidney transplantation.

Cheung CY, Chak WL.

Nephrology (Carlton). 2019 Feb;24(2):272. doi: 10.1111/nep.13426. No abstract available.

PMID:
30697886
19.

Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin.

Hallman BE, Hauck ML, Williams LE, Hess PR, Suter SE.

J Vet Intern Med. 2019 Mar;33(2):783-791. doi: 10.1111/jvim.15414. Epub 2019 Jan 29.

20.

Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.

Cao D, Zhang X, Akabar MD, Luo Y, Wu H, Ke X, Ci T.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):181-191. doi: 10.1080/21691401.2018.1548470.

PMID:
30686051

Supplemental Content

Loading ...
Support Center